Matches in SemOpenAlex for { <https://semopenalex.org/work/W1973806145> ?p ?o ?g. }
- W1973806145 endingPage "690.e2" @default.
- W1973806145 startingPage "682" @default.
- W1973806145 abstract "Purpose To evaluate the effect of the Boston Ocular Surface Prosthesis (Boston Foundation for Sight) on higher-order wavefront aberrations in eyes with keratoconus, eyes that have undergone penetrating keratoplasty, eyes that have undergone refractive surgery, and eyes with ocular surface diseases. Design Prospective, clinical study. Methods The study evaluated 56 eyes of 39 patients with irregular astigmatism who were treated with the Boston Ocular Surface Prosthesis when conventional treatments failed. Patients were sorted into 4 clinical groups based on the underlying cause of irregular astigmatism, including keratoconus (group 1), post–penetrating keratoplasty (group 2), post–refractive surgery (group 3), and ocular surface diseases (group 4). Another 6 eyes of 5 patients who were treated with rigid gas permeable lenses also were evaluated. Best-corrected visual acuity; topographic refractive indices, including spherical, cylindrical, spherical equivalent values; and higher-order and total wavefront aberration errors were noted at baseline and after fitting the lens. Results In all groups, higher-order wavefront aberration error was noted to decrease significantly in eyes wearing the Boston Ocular Surface Prosthesis (P < .001, P = .001, P = .002, and P = .001, respectively). By post hoc analysis, significant differences in the level of higher-order aberrations were observed only between groups 1 and 4 (P = .012) and groups 1 and 2 (P = .033). In the overall group, mean correction rate of higher-order aberration error with the Boston Ocular Surface Prosthesis was 72.3%. However, in eyes with rigid gas permeable lenses, 2 eyes demonstrated increased higher-order aberration error, whereas the mean correction rate in other 4 eyes was only 42.5%. Conclusions With its unique structure, the Boston Ocular Surface Prosthesis was found to be very effective in reducing higher-order wavefront aberrations in patients with irregular astigmatism resulting from a number of corneal and ocular surface conditions who had not responded satisfactorily to conventional methods of optical correction. To evaluate the effect of the Boston Ocular Surface Prosthesis (Boston Foundation for Sight) on higher-order wavefront aberrations in eyes with keratoconus, eyes that have undergone penetrating keratoplasty, eyes that have undergone refractive surgery, and eyes with ocular surface diseases. Prospective, clinical study. The study evaluated 56 eyes of 39 patients with irregular astigmatism who were treated with the Boston Ocular Surface Prosthesis when conventional treatments failed. Patients were sorted into 4 clinical groups based on the underlying cause of irregular astigmatism, including keratoconus (group 1), post–penetrating keratoplasty (group 2), post–refractive surgery (group 3), and ocular surface diseases (group 4). Another 6 eyes of 5 patients who were treated with rigid gas permeable lenses also were evaluated. Best-corrected visual acuity; topographic refractive indices, including spherical, cylindrical, spherical equivalent values; and higher-order and total wavefront aberration errors were noted at baseline and after fitting the lens. In all groups, higher-order wavefront aberration error was noted to decrease significantly in eyes wearing the Boston Ocular Surface Prosthesis (P < .001, P = .001, P = .002, and P = .001, respectively). By post hoc analysis, significant differences in the level of higher-order aberrations were observed only between groups 1 and 4 (P = .012) and groups 1 and 2 (P = .033). In the overall group, mean correction rate of higher-order aberration error with the Boston Ocular Surface Prosthesis was 72.3%. However, in eyes with rigid gas permeable lenses, 2 eyes demonstrated increased higher-order aberration error, whereas the mean correction rate in other 4 eyes was only 42.5%. With its unique structure, the Boston Ocular Surface Prosthesis was found to be very effective in reducing higher-order wavefront aberrations in patients with irregular astigmatism resulting from a number of corneal and ocular surface conditions who had not responded satisfactorily to conventional methods of optical correction." @default.
- W1973806145 created "2016-06-24" @default.
- W1973806145 creator A5020228004 @default.
- W1973806145 creator A5049004483 @default.
- W1973806145 creator A5086607086 @default.
- W1973806145 date "2011-04-01" @default.
- W1973806145 modified "2023-09-27" @default.
- W1973806145 title "The Impact of the Boston Ocular Surface Prosthesis on Wavefront Higher-Order Aberrations" @default.
- W1973806145 cites W106503042 @default.
- W1973806145 cites W1971340436 @default.
- W1973806145 cites W1974046502 @default.
- W1973806145 cites W1974763854 @default.
- W1973806145 cites W1977195053 @default.
- W1973806145 cites W1982430546 @default.
- W1973806145 cites W1991945678 @default.
- W1973806145 cites W2005969625 @default.
- W1973806145 cites W2006371816 @default.
- W1973806145 cites W2009577778 @default.
- W1973806145 cites W2017574867 @default.
- W1973806145 cites W2019832935 @default.
- W1973806145 cites W2021995065 @default.
- W1973806145 cites W2024619454 @default.
- W1973806145 cites W2030598848 @default.
- W1973806145 cites W2031308893 @default.
- W1973806145 cites W2035037081 @default.
- W1973806145 cites W2041159919 @default.
- W1973806145 cites W2049925794 @default.
- W1973806145 cites W2053169552 @default.
- W1973806145 cites W2065229096 @default.
- W1973806145 cites W2077545045 @default.
- W1973806145 cites W2079944557 @default.
- W1973806145 cites W2083762757 @default.
- W1973806145 cites W2084434126 @default.
- W1973806145 cites W2101342204 @default.
- W1973806145 cites W2104014666 @default.
- W1973806145 cites W2109262920 @default.
- W1973806145 cites W2127404287 @default.
- W1973806145 cites W2132094301 @default.
- W1973806145 cites W2135235113 @default.
- W1973806145 cites W2143346505 @default.
- W1973806145 cites W2144951850 @default.
- W1973806145 cites W2149917223 @default.
- W1973806145 cites W2159333131 @default.
- W1973806145 cites W2398392537 @default.
- W1973806145 cites W8311450 @default.
- W1973806145 doi "https://doi.org/10.1016/j.ajo.2010.10.027" @default.
- W1973806145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21269603" @default.
- W1973806145 hasPublicationYear "2011" @default.
- W1973806145 type Work @default.
- W1973806145 sameAs 1973806145 @default.
- W1973806145 citedByCount "53" @default.
- W1973806145 countsByYear W19738061452012 @default.
- W1973806145 countsByYear W19738061452013 @default.
- W1973806145 countsByYear W19738061452014 @default.
- W1973806145 countsByYear W19738061452015 @default.
- W1973806145 countsByYear W19738061452016 @default.
- W1973806145 countsByYear W19738061452017 @default.
- W1973806145 countsByYear W19738061452018 @default.
- W1973806145 countsByYear W19738061452019 @default.
- W1973806145 countsByYear W19738061452020 @default.
- W1973806145 countsByYear W19738061452021 @default.
- W1973806145 countsByYear W19738061452022 @default.
- W1973806145 countsByYear W19738061452023 @default.
- W1973806145 crossrefType "journal-article" @default.
- W1973806145 hasAuthorship W1973806145A5020228004 @default.
- W1973806145 hasAuthorship W1973806145A5049004483 @default.
- W1973806145 hasAuthorship W1973806145A5086607086 @default.
- W1973806145 hasConcept C109821595 @default.
- W1973806145 hasConcept C118487528 @default.
- W1973806145 hasConcept C120665830 @default.
- W1973806145 hasConcept C121332964 @default.
- W1973806145 hasConcept C141071460 @default.
- W1973806145 hasConcept C165699331 @default.
- W1973806145 hasConcept C165788157 @default.
- W1973806145 hasConcept C2776882836 @default.
- W1973806145 hasConcept C2778257484 @default.
- W1973806145 hasConcept C2778715743 @default.
- W1973806145 hasConcept C2778918178 @default.
- W1973806145 hasConcept C2781053140 @default.
- W1973806145 hasConcept C2781135284 @default.
- W1973806145 hasConcept C71924100 @default.
- W1973806145 hasConceptScore W1973806145C109821595 @default.
- W1973806145 hasConceptScore W1973806145C118487528 @default.
- W1973806145 hasConceptScore W1973806145C120665830 @default.
- W1973806145 hasConceptScore W1973806145C121332964 @default.
- W1973806145 hasConceptScore W1973806145C141071460 @default.
- W1973806145 hasConceptScore W1973806145C165699331 @default.
- W1973806145 hasConceptScore W1973806145C165788157 @default.
- W1973806145 hasConceptScore W1973806145C2776882836 @default.
- W1973806145 hasConceptScore W1973806145C2778257484 @default.
- W1973806145 hasConceptScore W1973806145C2778715743 @default.
- W1973806145 hasConceptScore W1973806145C2778918178 @default.
- W1973806145 hasConceptScore W1973806145C2781053140 @default.
- W1973806145 hasConceptScore W1973806145C2781135284 @default.
- W1973806145 hasConceptScore W1973806145C71924100 @default.
- W1973806145 hasFunder F4320320020 @default.
- W1973806145 hasFunder F4320332161 @default.
- W1973806145 hasFunder F4320332585 @default.